MedPath

The effect of Alprostadil on improvement of acute asthma attack

Phase 2
Conditions
Asthma.
Mixed asthma
Registration Number
IRCT2016052828129N1
Lead Sponsor
Vice chancellor for research, Ahwaz Judishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

age range of 18 to 65 years; proved diagnosis of asthma based on primary outcomes (wheezing, cough, and breathlessness triad).
Exclusion criteria: pulmonary diseases similar to asthma (such as interstitial lung disease)? having proven coagulation disorders and being treated with anticoagulants? history of chronic bronchitis; having acute medical disorders, cardiac, coronary vascular and arrhythmia diseases? being pregnant; treating with beta agonist nebulizers during last 6 hours, using cigarette more than 10 packs in year.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Forced expiratory volume in 1 second. Timepoint: Before intervention and in 20, 40, and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Peak expiratory flow rate. Timepoint: Before intervention and in 20, 40, and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Clinical symptoms severity. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.
Secondary Outcome Measures
NameTimeMethod
Respiratory rate. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Pulse rate. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Blood pressure rate. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Atrial oxygen saturation. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Level of consciousness. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Wheezing. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Borg dyspnea scale.;Using respiratory peripheral muscles. Timepoint: Before intervention and 40 minutes after intervention. Method of measurement: Borg dyspnea scale.
© Copyright 2025. All Rights Reserved by MedPath